BioGenerator is the investment arm of BioSTL.

BioGenerator produces a sustained pipeline of successful bioscience companies and entrepreneurs in St. Louis by creating, growing and investing in biotech startups.

BioGenerator is a nonprofit subsidiary of BioSTL, which advances St. Louis’ prosperity by cultivating a thriving bioscience sector, building regional capacity to capitalize on St. Louis’ world-class medical and plant biosciences.

For more information, visit BioGenerator or follow their updates on:

Locations

Financials

  • 24

BioGenerator Articles

Mighty Cricket Awarded $650,000 USDA Grant to Transform Food Waste into Cricket Feed

Jonathan Allen
4 Min Read

Shared Services in the St. Louis AgTech and BioTech Innovation Districts

Mike Fabrizi
11 Min Read

Big Pharma Teams Up with St. Louis Immunotherapy Startup & Why it Matters

Jonathan Allen
4 Min Read

St. Louis Manufacturing: Tradition and New Direction

Mike Fabrizi
9 Min Read

STL AgTech Ecosystem Partners to Offer 5 Arch Grants to AgriFoodTech Startups

EQ Staff, Jonathan Allen
2 Min Read

St. Louis Startup Scene: Balto Opens Office, Brain-Computer Interface Cleared to Sell

Paul Riat, 4thEst8
2 Min Read

Insect Control AgTech Startup Raises $1M

EQ Staff, Jonathan Allen
2 Min Read

Canopy Biosciences Acquired by Bruker After 4 Years As BioGenerator Incubated Startup

EQ Staff, Jonathan Allen
2 Min Read

In 2019, BioGenerator Invested $3.2 Million in 16 Bioscience Companies in St. Louis

EQ Staff, Jonathan Allen
3 Min Read

BioGenerator’s New Strategies Address St. Louis’ Talent Shortage

St. Louis Post-Dispatch
< 1 Min Read